Free articles: Pharma & healthcate

• The clinical trials market in CIS countries continues to grow February 2012

  Clinical trials in the CIS countries have been developing in a positive fashion (with the exception of Russia, whose development slowed for a while as a result of significant changes in regulations). The expected average growth in value will reach 14% and approximately 13% by volume in the years 2012-2014, according to the…

• Boom expected on medical equipment market in Poland in 2013 December 2011

  In 2010 the overall Polish medical equipment market grew by 5% year on year. The increase primarily reflected imports, which grew by 6%, to PLN 3.9bn (€1.0bn). According to the most recent PMR report “Medical devices market in Poland 2012. Development forecast for 2012-2014”, the market experienced…

• Growth forecasts for the Polish market of dietary supplements December 2011

  In 2011-2013, the market of dietary supplements in Poland will develop at a rate of 9-15% annually, according to the latest report published by PMR entitled „Dietary supplements market in Poland 2011. Development forecasts for 2011-2013”. Although the market growth rate is lower than in the preceding year,…

• OTC market in Central and Eastern Europe expected to grow by 9% per annum between 2011 and 2013 October 2011

  In 2010 OTC product pharmacy sales in Central and Eastern Europe (CEE) were worth €10.7bn, a 13% year on year increase in euro. Between 2011 and 2013 the market should develop by around 9% on average per annum, according to our latest report, entitled “OTC market in Central and Eastern Europe 2011. Comparative…

• Extensive consolidation confined to the retail industry in Russia October 2011

  In recent years consolidation on the Russian market has taken place mostly in the retail, whereas there has been stagnation on the wholesale market. In Ukraine acquisitions in both wholesale and retail pharmaceutical distribution stopped because of the more cautious policies of companies during the crisis, according to…

• Non-pharmacy market of OTC products in Poland in 2011-2013 September 2011

  According to our estimates, in 2009 the non-pharmacy market of OTC products (comprising medicines and dietary supplements) rose by around 11% year on year and exceeded PLN 1bn (€231m) for the first time on record. The year 2010 was a period of poorer growth for the pharmaceutical market as a whole, as reflected…

• Is the development of private healthcare market in Ukraine more rapid than that of Russia? September 2011

  The private healthcare markets in Russia and Ukraine are at the initial stage of development. Informal spending is widespread and this is partially caused by lack of proper payment mechanisms in the system. At the same time the private health insurance segment is immature. According to the latest PMR report, “Private…

• OTC market in Central and Eastern Europe: what should we expect in 2011-2013? September 2011

  In 2009 the OTC product market in the region was worth around €9.2bn, rising only 1% y-o-y, according to our report “OTC market in Central and Eastern Europe 2011. Development forecasts for 2011-2013”. What are the key future trends which may influence market growth in the coming years? Russia,…

• Pharmaceutical contract manufacturing and API sourcing: why not Central Europe? August 2011

  At present, only a few companies based in Central Europe and the Balkans emphasise their contract manufacturing and API sourcing services. There is relatively strong competition from companies from the Far East and from Western Europe. On the other hand, the potential of the region seems to be considerable, with Poland…

• Private healthcare in Central Europe expected to recover from crisis between 2011 and 2013 July 2011

  Investment activity started to pick up again on the private healthcare market in Central Europe in 2010 and 2011. Many companies returned to abandoned projects, and this resulted in new establishments being opened in 2011, particularly in Romania. However, public healthcare systems in the CE region continued to be underfunded…